Asian Journal of Cardiology Research

Obstructive Hypertrophic Cardiomyopathy: A Potential Threat during Pregnancy

S. Abouradi *

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

S. Zagdan

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

K. Badaoui

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

O. S. Obeidat

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

A. Asklou

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

L. Azzouzi

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

R. Habbal

Cardioloy Department, Ibn Rochd Hospital University, Casablanca, Morocco.

*Author to whom correspondence should be addressed.

---

Abstract

Hypertrophic cardiomyopathy (HCM) is a disease that can be both clinically and genetically diverse and is a significant factor behind unexpected death and heart failure. Typically, it occurs in the left ventricular ejection pathway, leading to obstruction in the ejection tract.

We present two cases of obstructive hypertrophic cardiomyopathy occurring in pregnant women, with a different evolution, monitoring, and management between the two cases.

Pregnant women with this disease require special attention because of potential complications. Close monitoring is necessary to minimize the risks.

Keywords: Hypertrophic cardiomyopathy, pregnancy, ejection tract obstruction

---

---

---

References

Semsarian C, Ingles J, Maron MS, Maron BJ. New insights into the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249-1254.

Armaan Shaikh, Tanvir Bajwa, Michelle Bush, A. Jamil Tajik, Successful alcohol septal ablation in a pregnant patient with symptomatic hypertrophic obstructive cardiomyopathy, Journal of Cardiology Cases. 2018 ;17(5):151-154.

Anjali Tiku Owens, Pregnancy in hypertrophic cardiomyopathy, European Heart Journal., 2017;38(35):2691-2692.

National Protocol for Diagnosis and Care.

Husser D, Ueberham L, Jacob J, Heuer D, Riedel-Heller S, Walker J, Hindricks G, Bollmann A. Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients. PLoS One. 2018;13(5):196-612.

Silbiger JJ. Mitral apparatus abnormalities in hypertrophic cardiomyopathy: echocardiographic, pathophysiologic, and surgical insights. J Am Soc Echocardiogr. 2016;29(7):622-39.

Minami Y, Kajimoto K, Terajima Y, Yashiro B, Okayama D, Haruki S, et al. Clinical implications of middle ventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011;57(23):2346-55.

Siu SC, Sermer M, Colman JM, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation. 2002;105: 2179-84.

Thaman R, Varnava A, Hamid MS, Firoozi S, Sachdev B, Condon M, Gimeno JR, Murphy R, Elliott PM, McKenna WJ. Pregnancy-related complications in women with hypertrophic cardiomyopathy. Heart. 2003;89(7):752-6.

Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy: the European Society of Cardiology (ESC) Working Group for the Diagnosis and Management of Hypertrophic Cardiomyopathy Eur Heart J. 2014;35(39):2733-2779.

Hirota Y, Furubayashi K, Kaku K, Shimizu G, Kino M, Kawamura K, et al. Non-obstructive hypertrophic cardiomyopathy: an accurate assessment of hemodynamic features and clinical implications. Suis J Cardiol. 1982;50(5):990-997.

Tanaka H, Kamiya C, Katsuragi S, Tanaka K, Miyoshi T, Tsuritani M, Yoshida M, Iwanaga N, Neki R, Yoshimatsu J, Ikeda T. Cardiovascular Events in Pregnancy with Hypertrophic Cardiomyopathy.

Lima FV, Parikh PB, Zhu J, Yang J, Stergiopoulos K. Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery. JACC Heart Fail. 2015;3(3): 257-66.

L'Écuyer É, Codsi E, Mongeon FP, Dore A, Morin F, Leduc L. Perinatal and cardiac outcomes of women with hypertrophic cardiomyopathy. J Matern Fetal Neonatal Med. 2022;35(25):8625-8630.

Schinkel, Arend FL. Grossesse chez les femmes atteintes de cardiomyopathie hypertrophique. Revue de cardiologie. 2014;22(5):217-222.

S. Goland, I.M. van Hagen, G. Elbaz-Greener, U. Elkayam, A. Shotan, W.M. Merz, et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC), European Heart Journal. 2017;38(35):2683-2690.